National Centre for Diseases Prevention and Health Promotion, National Institute of Health (Istituto Superiore di Sanità), Viale Regina Elena 299, 00161, Rome, Italy.
National Centre for Drug Research and Evaluation, National Institute of Health (Istituto Superiore di Sanità), Viale Regina Elena 299, 00161, Rome, Italy.
Health Res Policy Syst. 2020 Jan 29;18(1):12. doi: 10.1186/s12961-019-0523-1.
Promoting the well-being at all ages and reducing premature mortality from non-communicable diseases (NCDs) is a major target of the Sustainable Development Goals. In the frame of the JA-CHRODIS, a Strengths, Weaknesses, Opportunities and Threats (SWOT) analysis was conducted to provide different countries' insights on what makes a policy/programme addressing NCDs applicable, sustainable and effective, with a focus on diabetes.
A qualitative study has been performed using a SWOT analysis on policies/programmes at the national/federal or subnational level.
By March 2016, 14 SWOTs were conducted involving 11 European countries and 57 stakeholders and Ministries of Health, reporting and analysing a total of 44 policies. The main strengths, weaknesses, opportunities and threats have been outlined as well as and the main areas for governance improvement. A binding trans-sectoral approach is necessary to tackle the underlying risk factors of inequalities. The culture of disease prevention and health promotion is still low while the biomedical paradigm prevails. A systematic gender perspective is still missing. Sharing and exchange of best practices, as sponsored by the European Commission, is acting as a motivator.
The SWOT analyses draw an overall picture of the complexity of designing and implementing good policies and programmes that are tailored to local needs. These results may apply to any context and can be used by decision-makers, managers, professionals and other stakeholders to focus on key issues, recognising areas for attention.
促进全年龄段的健康福祉,降低非传染性疾病(NCD)导致的过早死亡率,是可持续发展目标的主要目标之一。在 JA-CHRODIS 框架内,进行了一次优势、劣势、机会和威胁(SWOT)分析,为不同国家提供了有关使针对 NCD 的政策/方案具有适用性、可持续性和有效性的见解,重点关注糖尿病。
采用 SWOT 分析方法对国家/联邦或国家以下各级的政策/方案进行了定性研究。
截至 2016 年 3 月,已完成了 14 项 SWOT 分析,涉及 11 个欧洲国家和 57 个利益攸关方和卫生部门,共报告和分析了 44 项政策。概述了主要的优势、劣势、机会和威胁,以及治理改进的主要领域。需要采取具有约束力的跨部门办法来解决不平等的根本风险因素。疾病预防和健康促进文化仍然较低,而生物医学模式仍然占主导地位。系统的性别视角仍然缺失。欧盟委员会赞助的最佳实践的交流与分享起到了激励作用。
SWOT 分析全面描绘了设计和实施针对当地需求的良好政策和方案的复杂性。这些结果可能适用于任何情况,决策者、管理者、专业人员和其他利益攸关方可据此关注关键问题,认识到需要关注的领域。